Carisma Therapeutics (CARM) Earnings Date, Estimates & Call Transcripts

$1.48
-0.03 (-1.99%)
(As of 05/10/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 8Estimated
Actual EPS
(Apr. 1)
-$0.52 Missed By -$0.52
Skip Charts & View Estimated and Actual Earnings Data

CARM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CARM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Carisma Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.47)($0.26)($0.37)
Q2 20242($0.45)($0.27)($0.36)
Q3 20242($0.43)($0.29)($0.36)
Q4 20242($0.47)($0.26)($0.37)
FY 20248($1.82)($1.08)($1.45)
Q1 20251($0.48)($0.48)($0.48)
Q2 20251($0.50)($0.50)($0.50)
Q3 20251($0.54)($0.54)($0.54)
Q4 20251($0.56)($0.56)($0.56)
FY 20254($2.08)($2.08)($2.08)

CARM Earnings Date and Information

Carisma Therapeutics last issued its earnings results on April 1st, 2024. The reported ($0.52) EPS for the quarter. The firm earned $4.29 million during the quarter, compared to analysts' expectations of $4 million. Carisma Therapeutics has generated ($2.00) earnings per share over the last year (($2.00) diluted earnings per share). Earnings for Carisma Therapeutics are expected to grow in the coming year, from ($1.65) to ($1.52) per share. Carisma Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off prior year's report dates.

Carisma Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/8/2024
Estimated)
------- 
4/1/2024Q4 2023-($0.52)($0.52)($0.52)$4.00 million$4.29 million
11/9/2023Q3 2023($0.60)($0.53)+$0.07($0.53)-$3.83 million
8/10/2023Q2 2023($0.66)($0.49)+$0.17($0.49)-$3.56 million
5/11/2023Q1 2023-($1.93)($1.93)($1.93)-$3.24 million
2/28/2023Q4 2022($2.20)($0.80)+$1.40($0.80)--
11/7/2022Q3 2022($1.60)$2.80+$4.40$3.60-$0.04 million
8/8/2022Q2 2022($2.60)($1.00)+$1.60$1.20--
2/28/2022Q4 2021($1.60)$0.40+$2.00--$20.00 million
11/8/2021Q3 2021($1.40)($0.40)+$1.00($8.00)--
8/9/2021Q2 2021($1.20)($1.40)($0.20)$0.20$2.40 million$2.23 million

Carisma Therapeutics Earnings - Frequently Asked Questions

When is Carisma Therapeutics's earnings date?

Carisma Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates. Learn more on CARM's earnings history.

How much revenue does Carisma Therapeutics generate each year?

Carisma Therapeutics (NASDAQ:CARM) has a recorded annual revenue of $14.92 million.

How much profit does Carisma Therapeutics generate each year?

Carisma Therapeutics (NASDAQ:CARM) has a recorded net income of -$86.88 million. CARM has generated -$2.00 earnings per share over the last four quarters.

What is Carisma Therapeutics's EPS forecast for next year?

Carisma Therapeutics's earnings are expected to grow from ($1.65) per share to ($1.52) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:CARM) was last updated on 5/11/2024 by MarketBeat.com Staff

From Our Partners